US Patent

US8931476 — Inhaler

Formulation · Assigned to Ivax Pharmaceuticals Ireland · Expires 2031-07-17 · 5y remaining

Vulnerability score 31/100 Strong — defensible against typical IPR challenges

What this patent protects

This patent protects an inhaler design, specifically a breath-actuated metered-dose inhaler, for delivering medicament to a patient.

USPTO Abstract

An inhaler, such as a breath-actuated metered-dose inhaler, for delivering medicament to a patient. The inhaler includes a housing for holding the medicament and having an air inlet and a medicament delivery port which together define an air flow path into which the medicament is dispensed. The air inlet includes an array of elongate apertures formed in the housing, the long sides of adjacent apertures facing each other. Each aperture is provided with a respective different opening in an outer surface of the housing. The opening of each aperture extends in two different planes such that, if at least a part of the opening is covered in one of the two different planes during inhalation by the patient, a void space is created between the cover and the aperture so as to provide an air flow path through the void space to the at least one aperture.

Drugs covered by this patent

Patent Metadata

Patent number
US8931476
Jurisdiction
US
Classification
Formulation
Expires
2031-07-17
Drug substance claim
No
Drug product claim
Yes
Assignee
Ivax Pharmaceuticals Ireland
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.